MENU
KYNB
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Kyntra Bio (KYNB) Earnings Date & Reports

Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease... Show more

A.I. Advisor
published Earnings

KYNB is expected to report earnings to fall 223.65% to -366 cents per share on November 09

Kyntra Bio KYNB Stock Earnings Reports
Q3'26
Est.
$-3.66
Q2'26
Beat
by $6.14
Q1'26
Missed
by $3.55
Q4'25
Missed
by $3.37
The last earnings report on August 13 showed earnings per share of $2.96, beating the estimate of -318 cents. With 5.15K shares outstanding, the current market capitalization sits at 20.41M.